These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14991543)

  • 1. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Oda S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2004 Feb; 35(2):240-5. PubMed ID: 14991543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.
    Sasaki M; Ishida T; Horiuchi H; MacHinami R
    Pathol Int; 1999 Sep; 49(9):799-806. PubMed ID: 10504551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
    Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
    Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microsatellite instability using Promega panel in dermatofibrosarcoma protuberans.
    Maeda-Otsuka S; Mijiddorj MT; Kajihara I; Nishimura Y; Kanemaru H; Sawamura S; Makino K; Aoi J; Masuguchi S; Fukushima S
    Biosci Trends; 2022 May; 16(2):176-177. PubMed ID: 35185112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
    Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
    Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
    Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
    J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
    Abbott JJ; Oliveira AM; Nascimento AG
    Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
    Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Ichiki T; Ito T; Shiraishi S; Nakashima Y; Nakahara T; Oda Y
    Sci Rep; 2024 Oct; 14(1):22973. PubMed ID: 39362949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change.
    Gu W; Ogose A; Kawashima H; Umezu H; Kudo N; Hotta T; Endo N
    J Clin Pathol; 2005 Sep; 58(9):984-6. PubMed ID: 16126884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
    Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
    Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
    J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
    Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
    Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
    Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
    J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for distant metastasis of dermatofibrosarcoma protuberans.
    Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Gokita T; Funauchi Y; Motoi N
    J Orthop Traumatol; 2016 Sep; 17(3):261-6. PubMed ID: 27289468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.